Refining Our Osteoporosis Treatment and Prevention Practices

/ Print /
| ShareMore
/ Text Size +
7/24/21 8:00 am EDT
Virtual Webinar

Webinar Overview:

Although osteoporosis is most prevalent among postmenopausal women, both genders and all age groups are at risk. Nevertheless, the condition is still overlooked and undertreated. Despite a plethora of prevention and screening recommendations, not many patients receive early diagnosis and effective care.

During this satellite symposium, a multidisciplinary panel will discuss the impact osteoporosis has on patients and the innovative strategies—pharmacologic and nonpharmacologic—that can improve outcomes. They will also present patient cases, review recent treatment guidelines, and examine the latest information on anti-catabolic and anabolic agents.

The learning objectives of this program are:

  • Discuss practical screening approaches in the primary care setting for patients at risk for osteoporosis
  • Outline guideline recommendations for use of osteoporosis therapies
  • Assess the efficacy and safety of current and emerging osteoporosis therapies
  • Develop multidisciplinary, individualized treatment plans for osteoporosis care in patients with complex needs

Target Audience

This educational program is directed toward OB/GYNs. PCPs, NPs, and PAs who treat women with osteoporosis are also invited to participate.

What You'll Experience

Benefits of Attending

  • Increase awareness of when and which patients should be screened for low bone mass
  • Gain familiarity with current guidelines on selection and duration of osteoporosis treatments
  • Learn the latest evidence for newer treatments and how they are incorporated into treatment plans
  • Put potential adverse effects of osteoporosis treatments into perspective 
  • Take on a holistic approach for each patient as part of a collaborative, multidisciplinary care team to reduce fracture risk and improve long-term outcomes 

Date and Time:

This webinar will be held on:

  • Saturday, July 24, 2021 8:00 AM - 9:00 AM EDT


Program Chair

John P. Bilezikian, MD

Chief, Division of Endocrinology
 Director of the Metabolic Bone Diseases Program
 Columbia University Medical Center
 Dorothy L. and Daniel H. Silberberg Professor of Medicine and Professor of Pharmacology
 College of Physicians & Surgeons, Columbia University
 New York, NY

Join PER® for this virtual, interactive event!

Explore the latest insights and advancements within this high-impact oncology CME meeting alongside our renowned faculty experts.

Accreditation Statement:

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.